[go: up one dir, main page]

DE69730152D1 - Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate - Google Patents

Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate

Info

Publication number
DE69730152D1
DE69730152D1 DE69730152T DE69730152T DE69730152D1 DE 69730152 D1 DE69730152 D1 DE 69730152D1 DE 69730152 T DE69730152 T DE 69730152T DE 69730152 T DE69730152 T DE 69730152T DE 69730152 D1 DE69730152 D1 DE 69730152D1
Authority
DE
Germany
Prior art keywords
protozoa
live bacteria
active immunity
generating active
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69730152T
Other languages
English (en)
Other versions
DE69730152T2 (de
Inventor
A Thoma
E Haddad
E Whitfill
P Avakian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arkansas at Fayetteville
Original Assignee
University of Arkansas at Fayetteville
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arkansas at Fayetteville filed Critical University of Arkansas at Fayetteville
Publication of DE69730152D1 publication Critical patent/DE69730152D1/de
Application granted granted Critical
Publication of DE69730152T2 publication Critical patent/DE69730152T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69730152T 1996-09-30 1997-09-26 Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate Expired - Lifetime DE69730152T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2708496P 1996-09-30 1996-09-30
US27084P 1996-09-30
PCT/US1997/017259 WO1998014212A1 (en) 1996-09-30 1997-09-26 Method of producing active immunity with vaccine conjugate

Publications (2)

Publication Number Publication Date
DE69730152D1 true DE69730152D1 (de) 2004-09-09
DE69730152T2 DE69730152T2 (de) 2005-11-03

Family

ID=21835595

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69730152T Expired - Lifetime DE69730152T2 (de) 1996-09-30 1997-09-26 Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate

Country Status (17)

Country Link
US (2) US6440408B2 (de)
EP (1) EP0951299B1 (de)
JP (1) JP4113588B2 (de)
KR (1) KR100382224B1 (de)
CN (1) CN100389827C (de)
AT (1) ATE272409T1 (de)
AU (1) AU715555B2 (de)
BR (1) BR9713312B1 (de)
CA (1) CA2264810C (de)
CZ (1) CZ94899A3 (de)
DE (1) DE69730152T2 (de)
EA (1) EA199900342A1 (de)
ES (1) ES2224273T3 (de)
ID (1) ID21338A (de)
IL (1) IL128014A (de)
PL (1) PL332540A1 (de)
WO (1) WO1998014212A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040233A1 (en) 1995-06-07 1996-12-19 Pfizer Inc. In ovo vaccination against coccidiosis
WO1996040234A1 (en) 1995-06-07 1996-12-19 Pfizer Inc. In ovo vaccination against coccidiosis
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
DE19828322A1 (de) * 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
KR20040030785A (ko) 2001-07-02 2004-04-09 화이자 프로덕츠 인크. 마이코플라즈마 하이오뉴모니애로의 1회 투여량 예방접종
MXPA04001882A (es) 2001-08-30 2004-06-15 Embrex Inc Metodos mejorados para producir oocistos.
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
WO2003099325A1 (en) * 2002-05-21 2003-12-04 Schering-Plough Ltd. Methods for the in vitro culture of sporozoea sp. and user thereof
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
AU2004294810C1 (en) * 2003-12-03 2013-02-14 Zoetis Services Llc In ovo vaccination of Campylobacter in avian species
MX2008012651A (es) * 2006-03-30 2009-03-06 Embrex Inc Procedimientos y composiciones para vacunacion de aves de corral.
US8040266B2 (en) 2007-04-17 2011-10-18 Cypress Semiconductor Corporation Programmable sigma-delta analog-to-digital converter
US20080311135A1 (en) * 2007-05-22 2008-12-18 Baylor College Of Medicine Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
WO2010141312A2 (en) * 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
ES2969952T3 (es) 2011-04-22 2024-05-23 Wyeth Llc Composiciones relacionadas con una toxina mutante de Clostridium difficile y sus procedimientos
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
RU2683027C2 (ru) * 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
WO2014110092A1 (en) * 2013-01-08 2014-07-17 Humabs Biomed Sa Methods of generating robust passive and active immune responses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1105136A (en) * 1964-03-25 1968-03-06 Wellcome Found Vaccines comprising living protozoa of the genus theileria
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
JP3020226B2 (ja) 1986-08-18 2000-03-15 ブリティッシュ・テクノロジー・グループ・リミテッド ワクチン
US4935007A (en) 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
US5026636A (en) * 1987-11-10 1991-06-25 The University Of Texas Board Of Regents Methods and compositions for production of mycoplasmal adhesins
DE3921255A1 (de) 1989-06-29 1991-01-03 Krebsoege Gmbh Sintermetall Verfahren zur erzeugung eines in einem traegergasstrom foerderbaren fluessigkeitsnebels und vorrichtung zur durchfuehrung des verfahrens
US5397568A (en) 1989-10-02 1995-03-14 Whitfill; Craig E. Method of treating infectious bursal disease virus infections
ATE200735T1 (de) 1989-10-02 2001-05-15 Univ Arkansas Impfstoffkonjugat
JP3078013B2 (ja) 1989-10-02 2000-08-21 エンブレックス インコーポレイテッド ワクチン接合体の使用方法、ワクチン調整物および製造品
CH682455A5 (fr) * 1991-07-25 1993-09-30 Serge Liotet Composition vaccinale.
US5378820A (en) * 1992-11-09 1995-01-03 Keeler; Calvin L. Gene encoding cytadhesin protein of mycoplasma gallisepticum and its use
US5641491A (en) * 1993-06-15 1997-06-24 The Penn State Research Foundation Escherichia coli strain 364 and use of said strain as a vaccine
WO1996040233A1 (en) * 1995-06-07 1996-12-19 Pfizer Inc. In ovo vaccination against coccidiosis
WO1997035619A1 (en) * 1996-03-28 1997-10-02 Genitrix, L.L.C. Opsonin-enhanced cells, and methods of modulating an immune response to an antigen

Also Published As

Publication number Publication date
PL332540A1 (en) 1999-09-13
US20020015706A1 (en) 2002-02-07
KR20000048622A (ko) 2000-07-25
EP0951299A1 (de) 1999-10-27
JP4113588B2 (ja) 2008-07-09
US6890527B2 (en) 2005-05-10
BR9713312A (pt) 2000-02-01
ID21338A (id) 1999-05-27
CN1231614A (zh) 1999-10-13
US6440408B2 (en) 2002-08-27
ES2224273T3 (es) 2005-03-01
EP0951299B1 (de) 2004-08-04
CA2264810C (en) 2010-07-27
AU4595397A (en) 1998-04-24
BR9713312B1 (pt) 2009-08-11
US20030044414A1 (en) 2003-03-06
CZ94899A3 (cs) 1999-09-15
CN100389827C (zh) 2008-05-28
IL128014A (en) 2003-11-23
ATE272409T1 (de) 2004-08-15
JP2000507608A (ja) 2000-06-20
KR100382224B1 (ko) 2003-04-26
AU715555B2 (en) 2000-02-03
EA199900342A1 (ru) 1999-10-28
DE69730152T2 (de) 2005-11-03
IL128014A0 (en) 1999-11-30
WO1998014212A1 (en) 1998-04-09
CA2264810A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
DE69730152D1 (de) Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate
NO950881L (no) Nöytraliserende monoklonale menneske-antistoffer mot respiratorisk syncytialt virus
ATE160787T1 (de) Verfahren zur herstellung von hefe-glucanen
EP1077719A4 (de) Verabreichungssystem für impfstoffe
BRPI9912177B8 (pt) epítopos de célula auxiliar t artificiais como imunoestimuladores para imunógenos de peptídeo sintéticos, imunógenos de peptídeo e método para a produção dos mesmos
BR9007702A (pt) Metodo de tratamento
ATE236194T1 (de) Antigene polysaccharidfragmente mit einer terminalen 2,5-anhydro-d-mannosegruppevon gruppe b-streptococcus, typ ii und typ iii, und daraus hergestellte konjugatimpfstoffe
NZ524888A (en) Nucleic acids and proteins from streptococcus groups A & B
WO2001064751A3 (en) High potency recombinant antibodies and method for producing them
DK0853487T3 (da) Neutraliserende monoklonale antistoffer mod respiratorisk syncytial virus
ES8405071A1 (es) Un procedimiento de preparacion de conjugados inmunoenzimaticos.
NO932102L (no) Oligosakkarid avledet fra antigent polysakkarid erholdt fra et patogen
DE69638145D1 (de) Verfahren zur herbeiführung einer immuntoleranz mit hilfe von immuntoxinen
DE69619187D1 (de) Verfahren zur behandlung von motorischen defiziten
ATE359814T1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
ATE310750T1 (de) Verotoxin b untereinheit zur immunisierunug
HUP9902513A2 (hu) Aktív immunitás létrehozására szolgáló vakcinakonjugátumok
EP0836480A4 (de) Zusammensetzungen, welche adp-ribosyltransferase-aktivität ausweisen und methoden für ihre herstellung und die verwendung derselben
DE69630761D1 (de) Verfahren zur verminderung der renalen aufnahme von antikörperfragmenten
ATE309371T1 (de) Protein mit dnase-aktivität
NO980721L (no) Vaksiner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition